Clinical efficacy and safety of imatinib in the management of Ph+ chronic myeloid or acute lymphoblastic leukemia in Chinese patients
Yu Zhu, Si-Xuan Qian Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu Province, People's Republic of China Abstract: Imatinib mesylate is considered the standard first-line systemic treatment for patients wit...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-03-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/clinical-efficacy-and-safety-of-imatinib-in-the-management-of-ph-chron-a16024 |